Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-007489
Filing Date
2025-05-13
Accepted
2025-05-13 07:15:28
Documents
72
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pasg-20250331x10q.htm   iXBRL 10-Q 1648226
2 EX-10.1 pasg-20250331xex10d1.htm EX-10.1 49464
3 EX-31.1 pasg-20250331xex31d1.htm EX-31.1 16060
4 EX-31.2 pasg-20250331xex31d2.htm EX-31.2 15528
5 EX-32.1 pasg-20250331xex32d1.htm EX-32.1 6264
6 EX-32.2 pasg-20250331xex32d2.htm EX-32.2 6128
7 GRAPHIC pasg-20250331x10q001.jpg GRAPHIC 54087
  Complete submission text file 0001558370-25-007489.txt   6965209

Data Files

Seq Description Document Type Size
8 EX-101.SCH pasg-20250331.xsd EX-101.SCH 49764
9 EX-101.CAL pasg-20250331_cal.xml EX-101.CAL 45885
10 EX-101.DEF pasg-20250331_def.xml EX-101.DEF 182576
11 EX-101.LAB pasg-20250331_lab.xml EX-101.LAB 437199
12 EX-101.PRE pasg-20250331_pre.xml EX-101.PRE 328873
75 EXTRACTED XBRL INSTANCE DOCUMENT pasg-20250331x10q_htm.xml XML 1011950
Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Filer) CIK: 0001787297 (see all company filings)

EIN.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39231 | Film No.: 25937119
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)